Evidence map›Paper›PMID 35663047›Full record

ArticleBioMed research international2022

A Dual Level Analysis with Evolutionary Computing and Swarm Models for Classification of Leukemia.

Sunil Kumar Prabhakar, Semin Ryu, In Cheol Jeong, Dong-Ok Won

Abstract read
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sunil Kumar PrabhakarDepartment of Artificial Intelligence Convergence, Hallym University, Chuncheon, 24252 Gangwon, Republic of Korea.ORCID https://orcid.org/0000-0003-4019-2345
Semin RyuDepartment of Artificial Intelligence Convergence, Hallym University, Chuncheon, 24252 Gangwon, Republic of Korea.
In Cheol JeongDepartment of Artificial Intelligence Convergence, Hallym University, Chuncheon, 24252 Gangwon, Republic of Korea.
Dong-Ok WonDepartment of Artificial Intelligence Convergence, Hallym University, Chuncheon, 24252 Gangwon, Republic of Korea.ORCID https://orcid.org/0000-0002-2839-6524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the major reasons of mortality in human beings is cancer, and there is an absolute necessity for doctors to identify and treat a person suffering from it. Leukemia is a group of blood cancers that usually originates in the bone marrow and results in very high number of abnormal cells. For the diagnosis of cancer, microarray data serves as an important clinical application and serves as a great aid to the entire medical community. The dimensionality of the microarray data is too high, and so selection of suitable genes is quite an important step for the improvement of data classification. Therefore, for the prediction and diagnosis of cancer, there is an utmost necessity to select the most informative genes. In this work, Minimum Redundancy Maximum Relevance (MRMR), Signal to Noise Ratio (SNR), Multivariate Error Weight Uncorrelated Shrunken Centroid (EWUSC), and multivariate correlation-based feature selection (CFS) are chosen as initial feature selection techniques. Then, to select the most informative genes, five different kinds of evolutionary optimization techniques too are incorporated here such as African Buffalo Optimization (ABO), Artificial Bee Colony Optimization (ABCO), Cockroach Swarm Optimization (CSO), Imperialist Competitive Optimization (ICO), and Social Spider Optimization (SSO). Finally, the optimized values are fed through classification process and the best results are obtained when multivariate CFS with SSO is utilized and classified with Probabilistic Neural Network (PNN), and a high classification accuracy of 95.70% is obtained.

Indexed as

LeukemiaNeoplasmsAlgorithmsHumansMicroarray Analysis

Identifiers

PMID35663047
PMCPMC9162867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.